Alexander Morris Ellen Ruth, Schroeder Megan E, Anderson Phelue N, Schroeder Lisa J, Monday Nicholas, Senties-Cue Gabriel, Ficken Martin, Ferro Pamela J, Suarez David L, Dimitrov Kiril M
Texas A&M Veterinary Medical Diagnostic Laboratory, College Station, TX 77843, USA.
Texas A&M Veterinary Medical Diagnostic Laboratory, Center, TX 75935, USA.
Viruses. 2025 May 3;17(5):670. doi: 10.3390/v17050670.
Newcastle disease, caused by virulent strains of avian paramyxovirus 1 (APMV-1), occurs globally and has significant social and economic impact. APMV-1 is a rapidly evolving RNA virus and is genetically divided into class I and class II with almost all virulent viruses being of class II. The considerable genetic diversity of the virus adds complexity to maintaining the high sensitivity and specificity of molecular detection assays. The current USDA's fusion gene rRT-PCR assay was designed for class II APMV-1 isolates with an emphasis on early-2000s US strains. Assessment with globally circulating genotypes confirmed previously described lower sensitivity (sub-genotypes VII.1.1, VII.2) and identified absence of detection (genotype XIV). An additional forward primer and two probes were designed using a comprehensive complete fusion gene sequence database. The optimized multiplex assay detected genotype XIV and improved sensitivity for sub-genotypes VII.1.1 and VII.2, with maintained sensitivity for the remaining genotypes. No near-neighbors or APMV-1 of low virulence were detected. Using field and experimental clinical samples, both the specificity and sensitivity were determined to be 100%, compared to the current assay with 100% and 93%, respectively. The new assay identifies all known chicken virulent APMV-1 genotypes with the benefit of using an exogenous internal positive control, which monitors extraction efficiency and inhibitors.
新城疫由禽副粘病毒1型(APMV-1)的强毒株引起,在全球范围内发生,具有重大的社会和经济影响。APMV-1是一种快速进化的RNA病毒,在基因上分为I类和II类,几乎所有强毒株都属于II类。该病毒相当大的遗传多样性增加了维持分子检测方法高灵敏度和特异性的复杂性。美国农业部目前的融合基因逆转录-聚合酶链反应(rRT-PCR)检测方法是针对II类APMV-1分离株设计的,重点是21世纪初的美国毒株。对全球流行基因型的评估证实了先前描述的较低灵敏度(VII.1.1、VII.2亚基因型),并发现无法检测到(XIV基因型)。利用一个全面的完整融合基因序列数据库设计了一条额外的正向引物和两个探针。优化后的多重检测方法能够检测到XIV基因型,并提高了VII.1.1和VII.2亚基因型的灵敏度,同时对其余基因型保持了灵敏度。未检测到近缘毒株或低毒力的APMV-1。使用现场和实验临床样本,与目前的检测方法(分别为100%和93%)相比,新检测方法的特异性和灵敏度均确定为100%。新检测方法能够识别所有已知的鸡源强毒APMV-基因型,且受益于使用外源内部阳性对照,该对照可监测提取效率和抑制剂。